Dear Editor,
An enigma exists with respect to the recognition and phagocytosis of phosphatidylserine (PS)-exposing cells. Vital PS-exposing cells (e.g. activated B cells1, 2 or neutrophils in Barth syndrome)3 are swallowed neither by amateur nor professional phagocytes. In this letter, we show that a restricted lateral mobility of PS in the plasma membrane might be responsible for this.
A common method of detecting PS on a cell surface is the use of the PS-binding protein Annexin V (AxV; MW: 35 kDa). Annexins are amphipathic molecules. Their interaction with anionic phospholipids is dependent on Ca2+ ions and reversible in the presence of chelators of divalent cations like EDTA.4, 5 Interestingly, some annexins, like AxV, build multimeric complexes on membrane surfaces. The calcium-induced formation of trimers, hexamers and bigger aggregates has been demonstrated.6 Therefore, the aggregation of AxV leads to the formation of planar crystals on artificial lipid bilayers. Several different shapes of the three-dimensional structure are described.7, 8 These complexes do not penetrate the membrane. AxV binds with high affinity to the negatively charged phospholipid PS. The Kd has been reported to have values between 15 and 0.03 nM.9, 10, 11 Cooperativity has been reported for the interaction with Ca2+.12
Freshly isolated, viable monocytes (00h-wo in Figure 1a) as shown by an intact mitochondrial membrane potential (Ψm; DiO6C), no morphological changes of the nucleus (nSSC), G1/0 DNA content (PI-Triton) and no detectable caspase activity (zVAD-fitc) were analysed for their AxV binding in the presence and absence of EDTA. Interestingly, these viable cells already showed a considerable amount of AxV-binding sites (PS). Note that the exposure by freshly isolated monocytes of PS is 1–2 orders of magnitude below that of their apoptotic counterparts (after UV irradiation; 24-uv in Figure 1a). The PS amount decreased during culture of the primary monocytes (24-wo). Instead, the number of necrotic cells slightly increased, as detected by PI staining. Apoptosis in irradiated cells (24-uv) was detected by loss of the Ψm, high caspase activity, sub-G1 DNA content and an increase of granularity.
In an attempt to investigate the binding efficiencies of AxV to PS on cells, we chose vital and dying cells as PS bearer to simulate the in vivo situation. This setting also has the advantage that, theoretically, PS is mobile and not fixed to any kind of rigid surface. In a quantitative analysis of the binding capacity for CD14, CD54 and PS, typical saturation curves could be detected for all three targets at high concentrations of the ligand (Figure 1b). Surprisingly, in the range under 50 nM AxV, the binding was below expectations (Figure 1b; arrow). The AxV (target PS)-binding curve revealed a strong sigmoid character as compared to the others. Curves like this are indications for a specific attribute of allosteric proteins (consisting of several subunits) named positive cooperativity. As examples for noncooperative binding curves, we titrated mAb to CD14 and CD54 (Figure 1b).
This indicates that a saturation of PS-binding sites on apoptotic cells was reached only above 250 nmol/l of AxV. For routine applications, concentrations around 500 nmol/l are used. AxV contains four PS-binding domains. Therefore, it can be calculated that approximately 109 binding sites for AxV were present on each apoptotic monocyte. The value for necrotic cells is up to 2.5 times higher. Vital monocytes on the other hand displayed six times less AxV-binding sites.
Thereafter, we analyzed whether AxV shows positive or negative cooperativity for PS binding on membranes. The classical way is the determination of the Hill coefficient (Figure 1c). A Hill coefficient above 1 indicates positive and below 1 negative cooperativity. A Hill coefficient of 1 indicates no cooperativity and follows the Michaelis–Menten scheme. We adjusted the Hill equation to the fact that we worked with two different units (fluorescence and concentration) that do not fit into the original equation. In analogy, we determined the factor of increase in fluorescence from one concentration of AxV, CD14 or CD54, respectively, to the doubled concentration (ΔF/C=ΔF/(2C/C)=ΔF/2). Strikingly, only AxV binding to apoptotic or necrotic but not to vital cells showed a nonlinear increase and produced a curve with a maximum at approximately 130 nmol/l. This is a second unequivocal evidence for a positive cooperative effect. The mAb CD14 and CD54 control were always close to 1 and, therefore, displayed no signs of a cooperative effect.
Especially note that vital monocytes (as an example of PS-exposing cells that are not phagocytosed (not shown)) did not promote cooperative binding. This suggests that AxV needs a critical density or clustering of PS molecules, or that its mobility is not sufficient for cooperative behavior. It might also be that AxV needs an undefined co-factor, which is present only on dying cells. As a matter of course, an overall binding constant cannot be determined from a cooperative interaction.
Afterwards, we analyzed the influence of increasing amounts of unlabeled AxV in competition with a fixed amount of labeled AxV to exclude that the cooperative effect was generated by the FITC label. Astonishingly, we found that competing FITC-labeled AxV with unlabeled AxV led to an increase in fluorescence up to an excess of at least 5.7 times for AxV concentrations below 100 nM. Even more surprising was the reversed experiment. Pre-incubation with varying amounts of unlabeled AxV and chasing with labeled AxV basically gave the same results. It can be concluded that unlabeled AxV cooperates with the FITC-labeled AxV and so increased the binding of free-labeled AxV. We showed that AxV binds to dying monocytes in a co-operative manner, as an example of cells that are phagocytosed (not shown).
In conclusion, we demonstrated that Annexin V displays homotrophic, positive cooperativity upon binding to membranes, with high PS amounts as found in dying cells. This means that one AxV physically interacts with another to change its conformation in such a way that it improves the binding abilities (lowers the binding energy) to PS. It has been described that AxV shows a crystal-like structure on PS liposomes.6 We propose that those crystals consist of AxV polymers. The AxV polymers are not due to covalent interactions because on/off rates can be seen when chasing with unlabeled AxV. This has also been demonstrated with human monoclonal antiphospholipid antibodies.13
PS exposure on apoptotic or necrotic cells is an ‘eat me’ signal for phagocytes.14 We demonstrated that PS is in the outer membrane leaflet of vital cells. But, in this case, it has obviously no ‘eat me’ function. We suggest that the PS density is too low to induce the ‘eat me’ signal. In analogy to the binding of AxV described in this letter, this may be due to a combination of the following reasons:
-
the membrane fluidity and, therefore, the mobility of PS is too low,
-
or the mechanisms for removing PS from the outer leaflet of the plasmamembrane (flip-flop) are too fast,
-
or the amounts of PS are too low for clustering of PS receptors in phagocytes, which might be necessary for the ‘eat me’ signal.
The data suggest a mechanism for phagocytes to differentiate dying and vital cells by means of PS clustering and/or lateral mobility due to membrane fluidity. This might explain why vital cells are not subject to phagocytosis.
References
Dillon SR et al. (2000) J. Immunol. 164: 1322–1332
Dillon SR et al. (2001) J. Immunol. 166: 58–71
Kuijpers TW et al. (2004) Blood 5: 5
Wu F et al. (1998) Biophys. J. 74: 3273–3281
Hawkins TE et al. (2002) Proc. Natl. Acad. Sci. USA 99: 8054–8059
Concha NO et al. (1992) FEBS Lett. 314: 159–162
Olofsson A et al. (1994) J. Struct. Biol. 113: 199–205
Voges D et al. (1994) J. Mol. Biol. 238: 199–213
van Heerde WL et al. (1994) Biochem. J. 302: 305–312
Sun J, Bird P and Salem HH (1993) Thromb. Res. 69: 289–296
Tait JF et al. (1992) Arch. Biochem. Biophys. 298: 187–191
Schlaepfer DD et al. (1987) Proc. Natl. Acad. Sci. USA 84: 6078–6082
Rand JH et al. (2003) Am. J. Pathol. 163: 1193–1200
Hirt UA and Leist M (2003) Cell Death Differ. 10: 1156–1164
Acknowledgements
This work was supported by the Federal Ministry of Education and Research (BMBF) (support number 01 KS 0002) and the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg (project number B28), by the responsif GmbH Erlangen, and the European Commissions EU (QLK3-CT-2002-02017_APOCLEAR).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Appelt, U., Sheriff, A., Gaipl, U. et al. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ 12, 194–196 (2005). https://doi.org/10.1038/sj.cdd.4401527
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401527
This article is cited by
-
Nanoscale imaging of CD47 informs how plasma membrane modifications shape apoptotic cell recognition
Communications Biology (2023)
-
FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia
Cell Death & Disease (2019)
-
Towards a pro-resolving concept in systemic lupus erythematosus
Seminars in Immunopathology (2019)
-
CD300c is uniquely expressed on CD56bright Natural Killer Cells and differs from CD300a upon ligand recognition
Scientific Reports (2016)
-
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
Cell Death & Differentiation (2016)